Refine and Redefine Intervention Using High-Definition (Hi-Def) Technology

The ability to magnify the field of view while increasing inherent spatial resolution with Hi-Def technology enhances visualization during critical aspects of endovascular interventions and has the potential to translate into additional accuracy and precision in X-ray imaging guided procedures with enhanced real time visualization during complex endovascular procedures.
Canon Medical provides an innovative technology with the world’s first Hi-Def detector—offering more than twice the spatial resolution of conventional flat panel detectors (FPD)—for resolving fine details. This unique hybrid 12" x 12" or 12" x 16" FPD combines high definition imaging technology based on CMOS that boosts spatial resolution up to 6.6 line pairs per millimeter (lp/mm) with 76 micron pixels (Figure 1). This unique Alphenix system offers the standard magnification modes 16", 12", 10", 8", 6" or 4.3" fields of view (FOV) and three additional Hi-Def modes with 3", 2.3" and 1.5" FOV, allowing increased spatial resolution without interruption of procedure workflow. At any given point in time, both modes are available, and when needed, the selection between the two modes can be quickly changed using an FOV switch, without adding additional delay to the procedure.

During intervention, using large FOV standard resolution FPD modes for coarse navigation, the catheter systems and devices are guided from the access site to just proximal to the lesion. Final placement and deployment of devices are performed under the magnified high-resolution Hi-Def modes with smaller FOVs (Figure 2). In a blinded-rater study that compared Hi-Def and FPD images, Hi-Def images were rated sharper and visually preferred [rated “much better” in 73% of instances] compared to the lower resolution images of the FPD.3

To assess the impact of improved visualization provided by the Hi-Def mode during cerebral aneurysm treatment a Pipeline Flow Diverter, a post-procedure physician survey was conducted in a single center study. Consecutive patients over a 10-month period treated with the use of the dual resolution imaging detector were included. A summary of the responses is presented in Figure 4 from a total of 25 cases.4 In all the cases reported, 100% of the time physicians either agreed or strongly agreed that Hi-Def mode visualization during the procedure was improved compared with standard FPD.
One critical aspect of deployment of a Pipeline Flow Diverter is the visualization of the distal end of the flow diverter as it is deployed and the subsequent opening of the device. Due to lack of radial forces, the distal end of the device may not immediately open. Visibility of this detail can dictate the next steps of the deployment procedure for instance wait for the distal end to open or re-sheath and redeploy the flow diverter. The high resolution Hi-Def modes offer the interventionalist a definite advantage in accurate placement and deployment of devices.

Advancements in medical device and imaging technology as well as accruing clinical evidence have accelerated the growth of endovascular treatment of cerebrovascular diseases. However, these procedures often necessitate the acquisition of many high-quality image sets and the use of long total fluoroscopy times, resulting in patients being potentially exposed to considerable radiation dose levels. And, with an increasing number of neurointerventional procedures being spurred by rapid advances in minimally invasive techniques and technologies for image guidance, this trend is likely to continue in the future. To mitigate this risk of unnecessary radiation exposure, and to provide data for decision support in justification and optimization, patient radiation dose tracking is considered to be of crucial importance. The ALARA principle, to limit radiation dose to “as low as reasonably achievable” should always be used; however, radiation doses should not be reduced at the expense of necessary image quality. Efforts focused solely on minimizing instantaneous radiation dose rates may paradoxically result in higher cumulative radiation dose delivered to the patient if there is an increase in overall irradiation time and/or increased utilization of higher dose acquisition modes to overcome inadequate visualization.
To quantify the clinical impacts and radiation dose of this novel dual-resolution detector, DICOM Radiation Dose Structured Report (RDSR) data was collected for all neurointerventional procedures performed before and after installation of the Hi-Def detector at a single center over a 45-month period. There were 1,702 pre- and 4,598 post-Hi-Def cases encompassing over 400,000 irradiation events in total. Normal and high-resolution magnification modes could be freely selected via the push of a button within the user interface. No other modifications were made to either the equipment or clinical protocols. Data from all cases were included and represented an equal mix of approximately 50% diagnostic and 50% interventions which remained consistent in both pre/post populations. A real-time patient skin dose tracking system (DTS) was used to monitor peak skin dose during the Hi-Def cases (Figure 5). A two-sample Student’s t-test analysis was performed to compare various technical parameters included in the RDSR. And, to further investigate any potential impacts on radiation dose, the cumulative air kerma, dose area product, and peak skin dose were plot as a function of Hi-Def utilization as a percentage of the total number of irradiation events (Figure 6).

Hi-Def imaging modes were utilized in 22% of procedures post installation with an exponential increase of 12% to 52% from the shortest (simplest) to longest (most complex) interventions. This suggests the greatest impacts of higher resolution were realized where additional information content may be of critical importance, for example in assessing vessel wall apposition of a device or the packing density of a coil mass. Hi-Def accounted for 26% of irradiation events on average, when utilized, across all modes of operation with 68% in fluoroscopy, 21% in DSA, 8% in DA and 3% in one shot modes. Statistically significant reductions (p<0.03) were observed in procedure time (-9.2%), cumulative air kerma (-9.6%), fluoro time (-8.6%), number of x-ray pulses (-8.2%) and 3D spins (-12%). Further, these metrics were 28 to 56% lower compared to available state-of-practice data.6 Peak skin dose data was available for 1,518 cases with 97.7% and 99.5% of cases below 3Gy and 5Gy, respectively. No correlation was observed (R2 < 0.10) using a best of all fits for all dosimetric indications as a function of Hi-Def utilization (Figure 6).
Significant improvements were observed with the new Hi-Def interventional system providing inherent spatial resolution capabilities up to 6.6 line pairs per mm (Figure 7). The clinical data outlined above shows that this enhanced visualization can result in reducing both procedure time and overall exposures required to complete a procedure.